Fullerton, CA, United States of America

Jared Wiig

This inventor holds 1 USPTO granted patent and 5 published patent applications. Top assignee: Abbvie Inc.. Active years: 2025.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Jared Wiig

Introduction

Jared Wiig is an accomplished inventor based in Fullerton, CA (US). He has made significant contributions to the field of biotechnology, particularly in the study of neurotoxins. His work has implications for various medical applications, showcasing his innovative spirit and dedication to advancing science.

Latest Patents

Jared Wiig holds a patent for "Clostridium botulinum Serotype A Neurotoxin (BoNT/A) Sequence Variants." This patent represents his research into the variants of a potent neurotoxin, which can have important therapeutic uses. His innovative approach in this area has the potential to lead to new treatments and therapies.

Career Highlights

Wiig is currently employed at AbbVie Inc., a global biopharmaceutical company known for its focus on innovative medicines. His role at AbbVie allows him to collaborate with leading scientists and researchers in the field, further enhancing his contributions to biotechnology.

Collaborations

Throughout his career, Jared has worked alongside notable colleagues, including Robert R. Kehrer and Hui Xiang. These collaborations have enriched his research and expanded the impact of his work in the scientific community.

Conclusion

Jared Wiig's contributions to the field of biotechnology, particularly through his patent on neurotoxin variants, highlight his innovative capabilities and commitment to advancing medical science. His work at AbbVie Inc. and collaborations with esteemed colleagues further underscore his role as a significant inventor in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…